Change to SPC removal of statement;
This medicinal product has been authorised under a so‑called ’conditional approval’ scheme. This means that further evidence on this medicinal product is awaited. The European Medicines Agency will review new information on this medicinal product at least every year and this SPC will be updated as necessary.
Date of last renewal : 28 August 2013